Cesarman, Ethel
Weill Cornell Medicine,
United States
2025 Rank: 14533
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 513 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 14533 | 15587 |
| Total Cites | 24186 | 26468 |
| H-index | 71 | 75 |
| Hm-index | 26 | 27 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 459 | 470 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 5176 | 5597 |
| Number of Single+First+Last Authored Papers | 80 | 80 |
| Total Cites to Single+First+Last Authored Papers | 9057 | 9866 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 13453 | 14070 |
| Ratio of Total Citations to Distinct Citing Papers | 1.80 | 1.88 |
| Self-Citation Percentage |
8.62%
|
|
Cesarman, Ethel
Weill Cornell Medicine,
United States
2024 Rank: 14222
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 518 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 14222 | 14944 |
| Total Cites | 23214 | 25287 |
| H-index | 68 | 74 |
| Hm-index | 26 | 27 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 431 | 441 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 4950 | 5334 |
| Number of Single+First+Last Authored Papers | 78 | 78 |
| Total Cites to Single+First+Last Authored Papers | 8685 | 9436 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 12827 | 13387 |
| Ratio of Total Citations to Distinct Citing Papers | 1.81 | 1.89 |
| Self-Citation Percentage |
8.20%
|
|
Cesarman, Ethel
Weill Cornell Medicine,
United States
2023 Rank: 13595
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 503 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 13595 | 14373 |
| Total Cites | 22446 | 24452 |
| H-index | 67 | 72 |
| Hm-index | 25 | 27 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 412 | 422 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 4780 | 5152 |
| Number of Single+First+Last Authored Papers | 77 | 77 |
| Total Cites to Single+First+Last Authored Papers | 8423 | 9157 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 12298 | 12819 |
| Ratio of Total Citations to Distinct Citing Papers | 1.83 | 1.91 |
| Self-Citation Percentage |
8.20%
|
|
Cesarman, Ethel
Weill Cornell Medicine,
United States
2022 Rank: 13110
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 494 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 13110 | 13638 |
| Total Cites | 21409 | 23334 |
| H-index | 63 | 70 |
| Hm-index | 25 | 26 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 382 | 392 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 4582 | 4946 |
| Number of Single+First+Last Authored Papers | 75 | 75 |
| Total Cites to Single+First+Last Authored Papers | 8066 | 8778 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 11640 | 12130 |
| Ratio of Total Citations to Distinct Citing Papers | 1.84 | 1.92 |
| Self-Citation Percentage |
8.25%
|
|
Cesarman, Ethel
Weill Cornell Medicine,
United States
2021 Rank: 12908
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 490 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 12908 | 13595 |
| Total Cites | 20641 | 22500 |
| H-index | 63 | 68 |
| Hm-index | 24 | 26 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 364 | 374 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 4429 | 4786 |
| Number of Single+First+Last Authored Papers | 75 | 75 |
| Total Cites to Single+First+Last Authored Papers | 7798 | 8498 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 11183 | 11651 |
| Ratio of Total Citations to Distinct Citing Papers | 1.85 | 1.93 |
| Self-Citation Percentage |
8.26%
|
|
Cesarman, Ethel
Weill Cornell Medicine,
United States
2020 Rank: 12166
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Pathology
Rank in SubField 1: 451 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 12166 | 13202 |
| Total Cites | 19609 | 21344 |
| H-index | 62 | 66 |
| Hm-index | 24 | 25 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 323 | 331 |
| Number of Single+First Authored Papers | 27 | 27 |
| Total Cites to Single+First Authored Papers | 4222 | 4561 |
| Number of Single+First+Last Authored Papers | 73 | 73 |
| Total Cites to Single+First+Last Authored Papers | 7411 | 8073 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 10543 | 10959 |
| Ratio of Total Citations to Distinct Citing Papers | 1.86 | 1.95 |
| Self-Citation Percentage |
8.13%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.